PepTivator® CD19 CAR Immunogenicity, human

PepTivator® CD19 CAR Immunogenicity is a pool of lyophilized peptides, consisting mainly of 15-mer sequences with 11 amino acids (aa) overlap, covering the proprietary sequence of Miltenyi Biotec’s CD19 CAR protein, according to internal evaluation.

In vitro stimulation of antigen-specific T cells with PepTivator Peptide Pools causes the secretion of effector cytokines and the up-regulation of activation markers, which then allow the detection and isolation of antigen-specific T cells.

Related products for PepTivator® CD19 CAR Immunogenicity, human

Specifications for PepTivator® CD19 CAR Immunogenicity, human
Overview

PepTivator® CD19 CAR Immunogenicity is a pool of lyophilized peptides, consisting mainly of 15-mer sequences with 11 amino acids (aa) overlap, covering the proprietary sequence of Miltenyi Biotec’s CD19 CAR protein, according to internal evaluation.

In vitro stimulation of antigen-specific T cells with PepTivator Peptide Pools causes the secretion of effector cytokines and the up-regulation of activation markers, which then allow the detection and isolation of antigen-specific T cells.

Detailed product information
Background information

The peptide pools cover part of the sequence of an FMC63 scFv containing CAR, which is directed against the human CD19 protein. CAR T cells, which express CARs containing this domain, are frequently applied for the treatment of B cell related leukemia and lymphoma.

The PepTivator Peptide Pools have been specially developed for efficient in vitro stimulation of antigen-specific CD4+ and CD8+ T cells, as peptides of 15 amino acid length with 11 amino acid overlap represent the optimized solution for stimulating T cells in various applications. Stimulation of T cells with PepTivator Peptide Pools causes the secretion of effector cytokines and upregulation of activation markers, which then allows the detection or isolation of antigen-specific T cells. Quantitative, phenotypical, or functional analysis of antigen-specific T cell immunity can provide important information on the natural course of immune responses in healthy or immunocompromised individuals.